Microchip Technology Incorporated Form 10-Q Summary
Business Context and Reporting Period
Microchip designs, manufactures and sells embedded control semiconductor products, including microcontrollers, analog products, FPGAs, memory and related technologies, and licenses technology. Reportable segments are semiconductor products and technology licensing. This unaudited filing covers the three and nine months ended December 31, 2021, the third quarter and first nine months of fiscal 2022.
Business conditions remained exceptionally strong, but wafer fabrication, assembly and test capacity remained constrained. Management expects certain supply-chain constraints to continue through calendar 2022 and possibly beyond.
Financial Performance and Key Metrics
| Metric | Three Months Ended December 31 | Nine Months Ended December 31 |
|---|---|---|
| Net sales | $1,757.5 million, up 30.0% | $4,976.7 million, up 25.3% |
| Gross profit | $1,153.3 million | $3,229.2 million |
| Gross margin | 65.6%, versus 62.6% | 64.9%, versus 61.7% |
| Operating income | $515.0 million | $1,300.1 million |
| Operating margin | 29.3%, versus 18.2% | 26.1%, versus 17.4% |
| Net income | $352.8 million | $847.6 million |
| Diluted EPS | $0.62, versus $0.07 | $1.50, versus $0.44 |
| Operating cash flow | Not separately provided | $2,095.0 million, versus $1,467.3 million |
- Microcontroller revenue was $972.2 million in the quarter, up 33.9%, and $2,768.7 million for the nine months, up 29.0%.
- Analog revenue was $500.5 million in the quarter, up 34.3%, and $1,423.5 million for the nine months, up 28.9%.
- Technology licensing revenue was $32.0 million in the quarter and $92.2 million for the nine months.
- Interest expense declined to $62.1 million in the quarter and $199.2 million for the nine months, primarily due to debt paydown and lower variable borrowing costs.
- Debt settlement losses were $16.1 million in the quarter and $101.6 million for the nine months, compared with $142.1 million and $214.0 million, respectively, in the prior-year periods.
Balance Sheet, Debt and Liquidity
- Cash and cash equivalents were $313.5 million at December 31, 2021, compared with $280.0 million at March 31, 2021. Cash, cash equivalents and short-term investments totaled $315.5 million.
- Inventories increased to $768.2 million from $665.0 million; reported inventory days increased to 116 from 112. Management expects 120 to 125 inventory days at March 31, 2022.
- Principal debt outstanding was $8.04 billion, consisting of $7.14 billion of senior indebtedness and $903.0 million of convertible debt. Net carrying value of long-term debt was $7.87 billion.
- The company had $1.54 billion outstanding under its $2.75 billion unsecured revolving credit facility, which terminates December 16, 2026. The company was in compliance with its debt covenants at December 31, 2021.
- Fixed-rate debt totaled approximately $6.50 billion and variable-rate debt totaled approximately $1.54 billion. Management estimates that a 50-basis-point increase in interest rates would increase annual interest expense by approximately $7.7 million.
- Capital expenditures were $255.5 million for the nine months, versus $37.2 million in the prior-year period. The company expects to invest $400 million to $500 million in equipment and facilities during the next twelve months.
- Financing activities used $1,726.5 million of cash, including debt repayments, $363.0 million of dividends and $166.0 million of stock repurchases.
Material Changes Versus the Prior Comparable Period
- Revenue growth reflected strong demand, particularly for microcontrollers and analog products, as well as price increases used to offset higher supply-chain costs.
- Gross margin expanded by 300 basis points in the quarter and 320 basis points for the nine months. The improvement primarily reflected higher production levels, favorable capacity absorption, product mix and pricing; the prior-year periods included unabsorbed capacity charges.
- Operating expenses increased in absolute dollars, mainly due to higher compensation costs, but declined as a percentage of revenue. Acquired-intangible amortization also declined due to accelerated amortization methods.
- Operating cash flow increased substantially, while investing cash use increased due to capacity expansion and research and development equipment.
- The company repaid the $1.0 billion 3.922% 2021 Notes, reduced revolver borrowings, issued $1.0 billion of 0.983% 2024 Notes and settled portions of its convertible debt.
- In December 2021, the company amended and restated its credit agreement, releasing prior collateral and converting the revolving facility to unsecured borrowings.
- In November 2021, the board authorized $4.0 billion of stock repurchases. Approximately $166.0 million had been used by December 31, leaving approximately $3.83 billion available.
Guidance, Outlook, Risks and Unusual Items
- Management expects strong demand and continued operation at or above normal capacity if supply constraints persist, but expects wafer, assembly and test constraints through calendar 2022 and potentially longer.
- COVID-19 and the Omicron variant increased absenteeism and disrupted certain company, supplier and subcontractor operations. Local restrictions could reduce production or constrain customer shipments.
- The company relies materially on third-party wafer foundries, assembly providers and test contractors. Approximately 60% of nine-month sales came from products produced at outside wafer foundries.
- The Preferred Supply Program provides capacity priority to customers committing to twelve months of non-cancellable and non-reschedulable orders, but it does not guarantee supply and could create future inventory or customer-cancellation risks.
- Management believes existing liquidity, operating cash flow and revolver availability will meet anticipated requirements for at least the next twelve months. Future funding needs could increase for capacity expansion, dividends, repurchases, acquisitions or debt refinancing.
- The IRS issued a notice of deficiency for fiscal 2007 through fiscal 2012, primarily concerning transfer pricing. The company challenged the notice in Tax Court and believes the assessment lacks merit, but an adverse outcome could materially affect cash flows and results.
- Legal matters include shareholder and derivative litigation related to the Microsemi acquisition, an SEC investigation, and an arbitration claim by Continental alleging defective Atmel components. The company had approximately $100 million of potential liability considered possible but not probable in excess of accrued amounts.
- Goodwill and net intangible assets were $6.67 billion and $4.26 billion, respectively. No goodwill or intangible impairment charges were recorded during the reported periods.
- The company expects future accounting adoption of ASU 2020-06 to increase the carrying value of convertible debt, reduce reported interest expense and change diluted EPS calculations; the impact was still under evaluation.
- Other principal risks include semiconductor cyclicality, pricing pressure, foreign operations and sales, China-related trade restrictions, cybersecurity, intellectual-property claims, customer and distributor concentration, manufacturing yields, labor availability, tax changes and possible debt-refinancing constraints.
Investor Verification Priorities
- Verify whether supply constraints, capacity additions and the Preferred Supply Program support continued revenue growth without creating excess inventory or fulfillment obligations.
- Monitor gross-margin sustainability as capacity utilization, product mix, input costs and semiconductor pricing conditions normalize.
- Review the timing and funding of $400 million to $500 million of planned capital expenditures alongside dividends, repurchases and debt maturities.
- Assess leverage, convertible-debt conversion exposure and the company’s ability to refinance or repay approximately $5.10 billion of scheduled principal maturities during fiscal 2024 and fiscal 2025.
- Track the IRS transfer-pricing dispute, Microsemi-related litigation and Continental arbitration for potential cash or earnings impacts.
- Evaluate the effect of COVID-19, Omicron-related absenteeism, foundry availability, subcontractor disruptions and international trade restrictions on production and shipments.